Table 1 Demographic, Clinical, Scintigraphic and Pathological data of the 20 patients included in the study.
Patient | Sex | Age (years) | Nodule Topography | Nodule size (mm) | TI-RADS class | Bethesda system | Visual analysis pattern | R.I. | WOind (%) | Histology |
|---|---|---|---|---|---|---|---|---|---|---|
1 | F | 20 | LL | 34 | 4A | IV | 3 | 108.4 | −10 | DTC |
2 | F | 45 | RL | 35 | 4B | III | 3 | 75.5 | −23.6 | Benign Adenoma |
3 | F | 50 | RL | 16 | 4B | IV | 3 | 144.4 | −8 | DTC |
4 | F | 80 | RL | 45 | 4B | IV | 3 | 194.3 | −6.6 | DTC |
5 | F | 54 | LL | 33 | 4A | III | 2 | 42.7 | −40 | Colloid Goitre |
6 | M | 48 | RL | 27 | 3 | IV | 3 | 93.2 | −26.6 | Benign Adenoma |
7 | F | 24 | RL | 22 | 4A | III | 2 | 27.6 | −45 | Colloid Goitre |
8 | F | 33 | LL | 28 | 3 | III | 3 | 89 | −24.1 | Benign Adenoma |
9 | F | 66 | LL | 50 | 3 | IV | 2 | −24.4 | −34.9 | Benign Adenoma |
10 | M | 53 | RL-I | 25 | 4A | III | 2 | −3.7 | −21.4 | Benign Adenoma |
11 | F | 33 | RL | 47 | 3 | III | 2 | −15.5 | −23.5 | Benign Adenoma |
12 | F | 48 | LL | 22 | 4A | III | 2 | 45 | −39 | Benign Adenoma |
13 | F | 62 | RL | 26 | 3 | IV | 2 | 5.55 | −25.5 | Benign Adenoma |
14 | F | 78 | LL | 23 | 4A | III | 2 | −70 | −28.5 | Benign Adenoma |
15 | F | 52 | RL | 35 | 4B | IV | 2 | 6.61 | −33 | Benign Adenoma |
16 | F | 46 | LL | 27 | 4B | III | 2 | −18.6 | −28 | Benign Adenoma |
17 | F | 53 | LL | 22 | 4A | III | 2 | 12.5 | −35 | Benign Adenoma |
18 | F | 75 | RL | 30 | 4B | III | 3 | 42.5 | −30 | Benign Adenoma |
19 | M | 28 | I | 18 | 4A | IV | 2 | 48 | −17 | DTC |
20 | F | 61 | RL | 23 | 4B | IV | 2 | 40.4 | −26 | Benign Adenoma |
